Huge Huge Huge Huge Post With NEW Information (HHHHPWNI

New Post Public Reply Private Reply Replies (5) Message Board
joey68
Huge Huge Huge Huge Post With NEW Information
(HHHHPWNI for short)
Did I mention this stuff is HUGE?

Note :
The links in this post may only work from the original board it was written.

I bet the majority of investors have never seen this stuff before!
I was doing some DD and surprisingly came across new stuff I never found before.

To start, I found the manual for the wavstat4. I cant wait to see the updated version of the manual!

Heres the English version of the manual:
http://www.spectrascience.com/images/uploads/..._Rev_B.pdf

Great read, and guess what? For the first time that ive ever seen (because we’ve heard of it, but how many people have actually seen it).. the manual shows the CE Mark on Page 2.

The actual CE mark is called ‘CE 0459’ which is standard. Perfect!

The manual even shows the BACK of the WavSTAT4 on page 10!

Reading through this manual, I google searched some key words and boom! Pow! Zing! All this new DD started slapping me in the face. I have a frozen bag of peas on my eye to help with the swelling.

Anyways..
Above the CE mark, it says ‘ EMERGO EUROPE’ .

Going to the EMERGO group website:
http://www.emergogroup.com/services/europe/ne...mbursement

it talks about Europe’s reimbursement programs. If you don’t know what this is, do some DD and youll figure it out.

Anyways.. EMERGOs site says:
Quote:

The Dutch medical device reimbursement process involves a diagnosis-related group (DRG) system known as the DBC used for patient classification and cost containment, as well as health technology assessments ( HTAs ) to determine cost-effectiveness of treatments.


Notice it mentions HTAs.

I googled "HTA" "spectrascience" and up pops this website:


http://deviceaccess.co.uk/

On the website, if you scroll down and watch the first video titled, “ Market Access & Reimbursement ”…

check out the speaker at :30 seconds! Its Hughes Wielemans of Spectrascience! In the video, he says SCIE is very interested in being adopted in the UK. Well, just listen to the video and hear it for yourself.

Did you hear Hughes say he asked Michael Branagan-Harris how to enter the UK market?

Michael Branagan-Harris Linkedin:
https://uk.linkedin.com/in/michael-branagan-harris-7b4a938

Quote:
“CEO Device Access UK Ltd-Market Access & Reimbursement Consultancy for MedTech & Diagnostic Devices into NHS England”


Hes the CEO of Device Access! Now scroll down to the bottom of the device access website, and look at their Client list!

Spectrascience is a client of theirs!! Do you see it? Its right there in PLAIN SIGHT! Im seriously not making this stuff up. Spectrascience is utilizing Device Access’s resources to penetrate the UK Market . And what does this mean? It means Spectrascience has been ACTIVELY working on entering the UK MARKET since 2014!

And remember, that video is from 2014 which means as of this post, we are 2 YEARS ahead of when this video was published.


Now go to 3:36 seconds in the video and hear him talk again. This is the best part!

He says that SCIE tried to enter the market on their own in the past and it made them lose 1 and a half years. Although this may sound bad, it’s not. It shows very typical growing pains. It’s very common for companies to try to save money by ‘doing things on their own’ only to figure out they need outside help. (..like you’ve never tried to do something on youre own, only to later realize you needed help. I know I have.)

This shows me that, instead of CONTINUING to try to do it on their own, SCIE admitted they needed help, and sought professional assistance from Device Access. This is great because it shows SCIE’s management was willing to admit they needed assistance.

MANY companies die off because they refuse to seek outside assistance. But not SCIE! Now they have the assistance of Device Access and again, seeing this video was from 2014, more than likely, they are 2 years closer to being marketable in the UK. This also helps build ‘good debt’. I talked about this in a previous post. ‘Good debt’ stems from the saying ‘it takes money to make money’. Any money SCIE spent on Device Access is going towards future profits. EXCELLENT!


BOOM! Even MORE proof Spectrascience hasn’t been sitting on their rump doing nothing for the past several years. Like I said a thousand times, it can take YEARS to penetrate the medical market in order to get your product developed, tested, approved, marketed, and distributed. And now, the majority of this stuff is in the PAST and whats the logical next step??

SALES!

In this 10K? Who knows! But who cares! Sales should be coming regardless of whether or not they show up in this 10K or the next 10Q or the next 10Q after that. As a long investor, it doesn’t matter to me because until I see evidence that this company is going to fail, im not going anywhere. Every corner I turn, I keep finding more and more evidence of a probable success story for Spectrascience, and now the story unfolds even more knowing SCIE has been actively working on selling their product in the UK with Device Access.

DD strikes again. DD:43 / Naysayers: 0

Note
Any blubbering response from naysayers which do not include links clearly stating SCIE is not working on penetrating the UK market will be ignored (you won’t find any).

SpectraSCIENCE Inc. (SCIE) Stock Research Links

SCIE Board Company Profile Buy Rating Time & Sales News Filings Financials
View My Board Here:
http://investorshangout.com/Joeys-Investment-Board-91611/


Invite Only

There is a VERY HIGH degree of RISK involved in trading and investing. Only invest what you can afford to lose.

Disclaimer:
As used herein, the terms "You" and "Your" shall mean you, individually, the reader, and each other party on whose behalf you may use the contained information at any time.
All references to "My", "I", and “The writer of the above post” shall refer to the creator of the username Joey68.

Do NOT invest unless you are prepared to sustain a total loss of the money you have invested plus any commission or other transaction charges.

There is a very high degree of risk involved in trading and investing. Past results are not indicative of future returns. I assume no responsibility for your trading and investment results. You should NOT rely on the information in the above post to make any decision or take any action.

ALL OF MY STATEMENTS, including but not limited to, POSTS, MESSAGES, PRIVATE MESSAGES, and RESPONSES are OPINION and NOT fact and are for entertainment purposes only. Do your own research and make your own decisions based on your own conclusions.
ALL OF MY STATEMENTS, including but not limited to, POSTS, MESSAGES, PRIVATE MESSAGES, and RESPONSES are NOT advice, and are NOT designed to substitute the expertise and judgment of a professional. It is your responsibility to seek investment advice during all stages of your investments. It is your responsibility to evaluate the accuracy, completeness and usefulness of the information in the above post.
I am NOT a professional.
I do NOT work for you.
My posts are NOT investment advice. I am not paid to post.
There is no correlation between the number of posts I write per day and your assumed success of a company.
It is NOT my responsibility to inform you of my own personal investment decisions.
It is NOT my responsibility to inform you when it is time for you to buy, hold, and/or sell a position.
I have no control over, and am not responsible for the actions of others who copy, store, edit, change, prepare any derivative work of or alter in any way any of the content provided in my posts.
Errors and Omissions expected. The writer of the above post accepts no liability or responsibility for any errors or omissions contained in the above post or contained within this Disclaimer.
The writer of the above post shall NOT accept any liability for the accuracy or completeness of the information contained in the above post, for any reliance placed by any person on the information contained in the above post, or for any damage or loss, however caused, in connection with the use or reliance on any information contained in the above post.
The above post may contain links to websites owned and operated by third parties. These links are provided for informational purposes only and are NOT endorsed by the writer of the above post. The writer of the above post has no control over the contents of any linked website and bears no responsibility for the accuracy, legality, or content of the external site or for that of subsequent links.
YOU ACCESS ALL LINKS ENTIRELY AT YOUR OWN RISK.
The writer of the above post makes no warranties or representations, express or implied about such linked websites, the third parties they are owned and operated by, or the information contained on these websites.
The writer of the above post accepts no liability for any damage or loss, however caused, in connection with the use of or reliance on any information, material, products, or services contained on or accessed through any such linked websites.

There is a VERY HIGH degree of RISK involved in trading and investing. Only invest what you can afford to lose.
Scroll down for more posts ▼

Top 10 Most Recent News Articles

Fashion and Philanthropy Unite at UBCF Kick-off Party

Updated Category News Views 86

Exclusivity and Dedication Mix at UBCF Event When fashion and philanthropy get together, you better believe it's more than just a pleasant evening. The Frederick Anderson Collection is hosting a swanky cocktail reception, kicking off the United Breast Cancer Foundation's (UBCF) highly-anticipated Think Pink Gala, and it's shaping up to be a unique affair wrapped in...

Continue Reading
UBCF & GGP Join Forces for Nationwide Pink Bag Drive

Updated Category News Views 178

Caring Through Community: Pink Bag Events Unroll What do you get when compassion meets action? That's the story with the United Breast Cancer Foundation (UBCF) and GGP's Pink Bag Event. Here in 2026, these folks are doing something so damn important, you'd wonder why more don’t follow suit. For the fifth straight year, they're rolling out a campaign that bridges the gap...

Continue Reading
Zhimeng Biopharma Hits Key Milestone in ALS Drug Trial

Updated Category News Views 183

Pivotal Point for Zhimeng's ALS Efforts Folks, get this—Zhimeng Biopharma's rolling out the big guns here with a significant step forward in their ALS treatment quest. This company just wrapped up patient enrollment for their next-gen ALS drug, CB03-154. We're talking about 255 patients now on board for a Phase 2/3 trial. The ground's shaking a bit because this...

Continue Reading
SCANOLOGY's AirGO Pad Revolutionizes On-Site Inspections

Updated Category News Views 157

Mobile 3D Scanning — Finally, Some Real Innovation Gone are the days where engineers had to cart around bulky laptops just to finish a simple inspection. SCANOLOGY has thrown a real game-changer into the mix with their new AirGO Pad. It's essentially a slick tablet that keeps your scanning, inspecting, and reporting all in one place, right beside whatever tangled hunk...

Continue Reading
HanAll F&B Pioneers New Path for Domestic Rice Noodles

Updated Category News Views 227

New Spin on an Old Favorite: Rice Noodles Forget about the same old wheat noodles clogging up the pantry. HanAll F&B is revamping the noodle game with a homegrown twist, setting sights on a future where Korean rice isn't just for steaming, soup, or sushi. This outfit from Taebaek, Gangwon, has got its hands deep in the rice flour, finessing a patent that aims to make...

Continue Reading
Bass Angler Matt Robertson Reels in Record $1.25M Prize

Updated Category News Views 91

A New Era for Bass Fishing Payouts Who would have thought we'd see the day when bass fishing turned out to be as lucrative as a Wall Street handshake? But here we are, with Matt Robertson hauling in a whopping $1.25 million prize at World Bass Enterprises' first "The Champions" Tournament. We're not talking chump change here—this is the real deal in a sport often...

Continue Reading
Purina's Docuseries Wins Big at Daytime Emmys

Updated Category News Views 154

Unleashing a Winning Streak Forget stock price fluctuations—Purina Films has struck gold. In a world where brand stories often fall flat or feel contrived, Purina's 'A Different Breed' docuseries just bagged three Daytime Emmy® Awards. It's not every day you see corporate storytelling make a splash like this, but when you blend pets and riveting narratives, magic...

Continue Reading
BAIC FOTON Eyes Africa for Bold Expansion Moves

Updated Category News Views 179

Pushing the Pedal to the Metal in Africa So here's the thing. When a company like BAIC FOTON sets its sights on Africa, you best believe they're not just twiddling their thumbs. Coming off a strong streak in the commercial vehicle game—topping China's sales for 21 years and exports for 15—their ambitions are now married to a keen interest in Africa's burgeoning...

Continue Reading
NABEP's Strategic Push: 41 Rigs to Bolster Output

Updated Category News Views 208

On The Ground: NABEP's Expanding Venezuelan Presence Think of oil production as a high-stakes poker game where each drill and rig is a well-placed bet. North American Blue Energy Partners (NABEP) is going all in on Venezuela, boosting their rig fleet and pushing production capacity to new heights. Set your sights on November when NABEP's in-country fleet will hit 41 rigs...

Continue Reading
DKS Lawsuit Deadline: Investors Must Act by Nov 3, 2026

Updated Category News Views 78

Clock's Ticking for DICK'S Investors If you've got money tied up in DICK'S Sporting Goods—bought between September 8, 2025, and August 24, 2026—listen up. There's a class action lawsuit aiming to recover some of what might've slipped through your fingers. Come November 3, 2026, the door slams shut on your chance to get involved. What's the Beef? Apparently, DICK'S had...

Continue Reading

Top 5 Most Recently Viewed Articles

Morton's Restaurant Group Achieves 52-Week High of $3.70

Updated Category News Views 291

Morton's Restaurant Group Reaches a New High In an impressive turn of events in the stock market, Morton's Restaurant Group (MRT) has hit a remarkable 52-week high, reaching $3.7. This achievement not only highlights the company’s market dynamics but also signifies a market capitalization of approximately $204.5 million. Significant Annual Growth The growth trajectory...

Continue Reading
Enhancing Bone Health: A New Partnership in Australia

Updated Category News Views 96

The Global Healthy Living Foundation Australia (GHLF Australia) forged a partnership with The Bone Bus back then, aiming to pump up bone health access in rural spots where folks were really struggling. This initiative wasn't just some PR stunt; it targeted real issues surrounding osteoporosis that so many older Australians faced. Rural Access: A Tough Nut to Crack Let’s...

Continue Reading
Warrior Met Coal Declares New Quarterly Dividend for Shareholders

Updated Category News Views 110

Warrior Met Coal Declares New Quarterly Dividend BROOKWOOD, Ala. — Warrior Met Coal, Inc. (NYSE:HCC) has announced an exciting update regarding its dividend payments. The company's board of directors has approved a regular quarterly cash dividend of $0.08 per share. This is a remarkable achievement for Warrior and its dedicated stockholders. The Dividend Payment...

Continue Reading
AMVital's 97% Customer Satisfaction: A Deep Dive

Updated Category News Views 119

AMVital's Impressive Customer Satisfaction Rate AMVital, a groundbreaking skincare brand known for its turmeric-based formulations, has unveiled the results of an extensive customer review study. Analyzing over 13,000 verified reviews from multiple platforms like Shopify, Amazon, Walmart Marketplace, and TikTok Shop, they found an astounding satisfaction rate of 97%. This...

Continue Reading
Cisco's Impressive Performance Spurs Analysts to Boost Targets

Updated Category News Views 166

Cisco Systems Delivers Strong Earnings Amid AI Demand Shares of Cisco Systems Inc (NASDAQ: CSCO) surged in early trading after reporting impressive fiscal results for the first quarter. The robust demand for artificial intelligence (AI) infrastructure has been a significant contributor to this growth, as highlighted by various analysts across the finance sector. Analyst...

Continue Reading